Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.

@article{Mocroft2007RiskOD,
  title={Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.},
  author={Amanda Mocroft and Schlomo Staszewski and Rainer K. Weber and Jose Gatell and Jurgen K Rockstroh and Jacek Gąsiorowski and G. Panos and Antonella d'Arminio Monforte and Aza G Rakhmanova and Andrew N Phillips and Jens D. Lundgren},
  journal={Antiviral therapy},
  year={2007},
  volume={12 3},
  pages={325-33}
}
INTRODUCTION It is unknown whether the increased risk of toxicities in antiretroviral-naive HIV-infected patients initiating nevirapine-based (NVPc) combination antiretroviral therapy (cART) with high CD4+ T-cell counts is also observed when NVPc is initiated in cARTexperienced patients. PATIENTS AND METHODS 1,571 EuroSIDA patients started NVPc after 1/1… CONTINUE READING